BELGRADE, Serbia, June 02, 2026 (GLOBE NEWSWIRE) -- International crypto entertainment platform 1win has officially announced the signing of the full Tundra Esports Dota 2 roster. Effective June 1, professional players Pure, bzm, 33, Ari, and Whitemon compete under the 1win Team tag. Alongside the players, coach MoonMeander, esports analyst degaz, team manager Jamba, and sports director SweetyPotz are joining the organization.
The roadshow which took place under the theme "Investing in progress through the implementation of the Afreximbank mandate in The Bahamas" built on the...
MALMÖ, Sweden, June 2, 2026 /PRNewswire/ -- Sweden Rock Festival is taking further steps towards more sustainable food and drink experiences. Together with Duni...
SEOUL, South Korea, June 2, 2026 /CNW/ - Canada Pension Plan Investment Board (CPP Investments) and BlueCove Investment (BlueCove), a Korean hospitality-focused asset manager,...
TAIPEI, June 2, 2026 /PRNewswire/ -- MSI showcases a comprehensive portfolio of AI and data center infrastructure platforms at COMPUTEX 2026 (Booth #J0605a), with...
New York, June 01, 2026 (GLOBE NEWSWIRE) -- Tribeca Strategic Acquisition Corp. (the “Company”), announced today the closing of its initial public offering of 14,000,000 units at a price of $10.00 per unit, which resulted in gross proceeds of $140,000,000. The units are listed on the Nasdaq Global Market (“Nasdaq”) and began trading on May 29, 2026, under the ticker symbol “BIDWU.” Each unit consists of one Class A ordinary share and one right (the “Share Right”) to receive one tenth (1/10) of one Class A ordinary share upon the consummation of an initial business combination. There are no warrants issued publicly or privately in connection with this offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and Share Rights are expected to be listed on Nasdaq under the symbols “BID” and “BIDWR,” respectively.
DALLAS, June 1, 2026 /PRNewswire/ -- The nationally recognized plaintiffs' attorneys from Dallas' Hamilton Wingo have filed the first wrongful death lawsuit resulting from...
Tokyo, Japan and Cambridge, UK, 2 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) announces that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation to vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The Company plans to submit a Marketing Authorization Application (MAA) for vamorolone in South Korea during 2026.
Dragos expands to protect xOT including OT systems and the billions of connected devices that have reshaped how critical infrastructure operatesHANOVER, Md., June 2,...
DETROIT, June 1, 2026 /PRNewswire/ -- Point One Navigation, a leader in precision positioning and navigation software, is showcasing an ongoing collaboration with STMicroelectronics,...